Obesity and type 2 diabetes are becoming increasingly prevalent worldwide and are both associated with the increased incidence of kidney and bladder cancers. However, previous reports have provided conflicting results. We investigated the impact of body mass index (BMI) and diabetes on the incidence of both cancers in the general population. Using nationally representative data […]
Bladder cancer (BC), the most common malignancy of the urinary tract, accounts for 90-95% of all urothelial carcinomas (UCs), while upper urinary tract UC (UUTUC) accounts for only 5-10%. Radical nephroureterectomy with excision of bladder cuff, and radical cystectomy with pelvic lymph node dissection and a urinary diversion (UD) are the gold standard treatments for […]
Conventional cytology (CC) is a widely employed biomarker for the detection of bladder cancer, but due to its decreased sensitivity, liquid-based cytology (LBC) has been studied. Despite its improved cell-free background, decreased cell degeneration, and an automated slide preparation technique, it shows a variable rate of malignant cells detection. Thus, we did this study to […]
Racial/ethnic minority groups have a higher burden of renal cell carcinoma (RCC), but RCC among Hispanic Americans (HAs) and American Indians and Alaska Natives (AIs/ANs) are clinically not well characterized. We explored variations in age at diagnosis and frequencies of RCC histologic subtypes across racial/ethnic groups and Hispanic subgroups using National Cancer Database (NCDB) and […]
Increased computational power and improved visualization hardware have generated more opportunities for virtual reality (VR) applications in healthcare. In this study, we test the feasibility of a VR-assisted surgical navigation system for robotic-assisted radical prostatectomy.
Ashish Kamat: So welcome. It gives me great pleasure to have Dr. Stephen Williams with us today. He is a Director of Urologic Oncology and Director of Research as well as Chief of the Division of Urology and the Medical Director at UTMB Health System here in Texas in Galveston. Welcome Stephen, and it’s a […]
Tom Keene: Hello everybody. This is Tom Keene coming to you from UroToday. Today, we have a real treat. We have professor Seifker-Radtke who is coming to us from the division of cancer medicine at the University of Texas at MD Anderson Cancer Center where she is a professor of Genitourinary Medical Oncology. Arlene Siefker-Radtke: […]
Matthew Sydes: Thank you very much for having me here this morning. I’ve been asked to give a statisticians perspective on it. Being a statistician, I’m one of very few in the room with you today. For those of you who don’t like listening to statisticians speak, I rather than like this picture, please allow yourself […]
Himisha Beltran: Thank you for the invitation and for this fantastic meeting. When looking into the future for oligometastatic disease, I am quite optimistic that we will have made significant progress on refining our definitions for disease stratification. We will have nominated molecular biomarkers to help us better capture biologic disease states, which will ultimately help […]
Catheter-associated urinary tract infections (CAUTIs) represent the most common nosocomial infection. The authors’ baseline rate of CAUTI for general medical service was elevated at 36 per 1000 catheter-days. The medical literature has consistently linked inappropriate catheter use with the development of CAUTI. The baseline data also revealed a high rate of inappropriate use of indwelling […]
